Fate Therapeutics Stock Technical Analysis
| FATE Stock | USD 1.13 0.02 1.74% |
As of the 19th of July, Fate Therapeutics shows the Coefficient Of Variation of 21082.24, mean deviation of 4.82, and Downside Deviation of 6.23. Fate Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Fate Therapeutics variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and semi variance to decide if Fate Therapeutics is priced favorably, providing market reflects its regular price of 1.13 per share. Given that Fate Therapeutics is a hitting penny stock territory we advise to closely look at its total risk alpha.
Fate Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Fate, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to FateFate Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Fate Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Fate Therapeutics Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Fate Therapeutics across different markets.
Fate Therapeutics Trend Analysis
Use this graph to draw trend lines for Fate Therapeutics. You can use it to identify possible trend reversals for Fate Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Fate Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Fate Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Fate Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.0007 , which may suggest that Fate Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.02, which is the sum of squared deviations for the predicted Fate Therapeutics price change compared to its average price change.About Fate Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Fate Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Fate Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Fate Therapeutics price pattern first instead of the macroeconomic environment surrounding Fate Therapeutics. By analyzing Fate Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Fate Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Fate Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Fate Therapeutics July 19, 2025 Technical Indicators
Most technical analysis of Fate help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Fate from various momentum indicators to cycle indicators. When you analyze Fate charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0129 | |||
| Market Risk Adjusted Performance | 0.0173 | |||
| Mean Deviation | 4.82 | |||
| Semi Deviation | 5.93 | |||
| Downside Deviation | 6.23 | |||
| Coefficient Of Variation | 21082.24 | |||
| Standard Deviation | 6.26 | |||
| Variance | 39.18 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.33) | |||
| Total Risk Alpha | (0.86) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0073 | |||
| Maximum Drawdown | 29.08 | |||
| Value At Risk | (9.29) | |||
| Potential Upside | 9.6 | |||
| Downside Variance | 38.87 | |||
| Semi Variance | 35.2 | |||
| Expected Short fall | (5.18) | |||
| Skewness | 0.213 | |||
| Kurtosis | 1.21 |
Fate Therapeutics July 19, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Fate stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.05 | ||
| Daily Balance Of Power | (0.33) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 1.16 | ||
| Day Typical Price | 1.15 | ||
| Price Action Indicator | (0.04) | ||
| Market Facilitation Index | 0.06 |
Complementary Tools for Fate Stock analysis
When running Fate Therapeutics' price analysis, check to measure Fate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fate Therapeutics is operating at the current time. Most of Fate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Fate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fate Therapeutics' price. Additionally, you may evaluate how the addition of Fate Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |